ArticleJournal of cancer research and clinical oncology2020

Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.

Moiken Mehner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.